NFE2L2 and autoimmune polyendocrinopathy: Therefore, the Mirt2/NRF2/MAPK signaling pathway may provide novel insight into the initiation and development of lipid metabolism-associated diseases, including thrombosis, APS and AS, thus providing a novel therapeutic approach for these diseases.